This Schwab Holds Dividend Strategy Surges in 2026 So Far
Schwab’s dividend-focused ETF remains popular for income seekers amid a volatile market. As March rebalancing shifts ...
Investing
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
8,148 articles
Dividend ETFs with Over 6% Yields Stand Out in 2026
As the market keeps rates elevated, three dividend ETFs with over 6% yields offer straightforward income without upsi...
Paramount Looks Itself Driver’s Bold Bid for Warner
Paramount Global and Skydance are stepping up with a bigger offer for Warner Bros. Discovery, aiming to outpace Netfl...
Entertainment Hits Odds Beat: Can AMC Earn Real Returns?
As AMC gears up for earnings, investors are asking if the meme-stock buzz can turn into real profits. This article br...
Ways to Stretch Your Retirement Savings for Decades
Worried about funding a decades-long retirement? This guide shares actionable strategies to stretch your retirement s...
Dominion Energy 2025 Earnings: A Clear Look for Investors
Dominion Energy 2025 earnings shaped the 2026 outlook. This analysis breaks down the Q4 results, key drivers, and wha...
Why Viking Therapeutics Stock More Is Turning Heads Today
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
This Fund Nearly Million Bet on GRAIL: Lessons for Investors
A leading hedge fund poured nearly $40 million into GRAIL last quarter, only to see the stock tumble. This article un...
Home Depot Earnings Just Ahead: What Investors Expect
As Home Depot gears up to report, investors weigh EPS targets, margin dynamics, and housing trends. This guide breaks...
Kodiak Sciences Stock 480% Rally: Big Fund Buy Explained
A prominent hedge fund unveiled a sizable Kodiak Sciences stake, triggering chatter about what the kodiak sciences st...
Fluor Dumps Million Shares: What Investors Should Know
A major insider move is lighting up the markets as Fluor dumps million shares of NuScale SMR for $1.35 billion. Here’...
Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...